{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T16:11:24Z","timestamp":1774714284628,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.berh.2012.01.007","type":"journal-article","created":{"date-parts":[[2012,3,16]],"date-time":"2012-03-16T21:06:49Z","timestamp":1331932009000},"page":"91-104","source":"Crossref","is-referenced-by-count":22,"title":["Polymyalgia rheumatica in 2011"],"prefix":"10.1016","volume":"26","author":[{"given":"Alessandra","family":"Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Landolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2012.01.007_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.2.1450.811","article-title":"Senile rheumatologic gout","volume":"2","author":"Bruce","year":"1888","journal-title":"British Medical Journal"},{"key":"10.1016\/j.berh.2012.01.007_bib2","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/ard.16.2.230","article-title":"Myalgic syndrome with constitutional effects: polymyalgia rheumatica","volume":"16","author":"Barber","year":"1957","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/bmj.1.5329.513","article-title":"Prognosis in anarthritic rheumatoid syndrome","volume":"1","author":"Bagratuni","year":"1963","journal-title":"British Medical Journal"},{"issue":"Issue 1","key":"10.1016\/j.berh.2012.01.007_bib4","first-page":"8","article-title":"The overlap of rheumatoid arthritis and polymyalgia rheumatica in older patients","author":"Healey","year":"1989","journal-title":"Mediguide to Inflammatory Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib5","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/bmj.2.5212.1562","article-title":"Giant cell arteritis, or arteritis of the aged","volume":"2","author":"Paulley","year":"1960","journal-title":"British Medical Journal"},{"key":"10.1016\/j.berh.2012.01.007_bib6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(63)91861-0","article-title":"Giant cell arteritis: a biopsy study of polymyalgia rheumatica, including one case of takayasu\u2019s arteritis","volume":"1","author":"Alestig","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2012.01.007_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/ard.27.5.397","article-title":"\u2018Polymyalgia arteritica\u2019. Further clinical and histopathological studies with a report of six autopsy cases","volume":"27","author":"Hamrin","year":"1968","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"Suppl.","key":"10.1016\/j.berh.2012.01.007_bib8","first-page":"80","article-title":"Stenosing arteritis of the subclavian-axillary arteries (polymyalgia rheumatica sive arteritica)","volume":"465","author":"Hamrin","year":"1976","journal-title":"Acta Chirurgica Scandinavica"},{"key":"10.1016\/j.berh.2012.01.007_bib9","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.1985.03360190069027","article-title":"Remitting seronegative symmetrical synovitis with pitting edema. rs3pe syndrome","volume":"254","author":"McCarty","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.berh.2012.01.007_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.38.5.434","article-title":"An evaluation of criteria for polymyalgia rheumatica","volume":"38","author":"Bird","year":"1979","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.7326\/0003-4819-97-5-672","article-title":"Polymyalgia rheumatica: a 10-year epidemiologic and clinical study","volume":"97","author":"Chuang","year":"1982","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0049-0172(84)90012-X","article-title":"Long-term follow-up of polymyalgia rheumatica: evidence for synovitis","volume":"13","author":"Healey","year":"1984","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/ard.40.1.1","article-title":"Prognosis and management of polymyalgia rheumatica","volume":"40","author":"Jones","year":"1981","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib14","first-page":"1694","article-title":"Trends in the incidence of polymyalgia rheumatica over a thirty-year period in Olmsted County, Minnesota, USA","volume":"29","author":"Doran","year":"2002","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzales-Gay","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.berh.2012.01.007_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/art.1780380311","article-title":"Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970\u20131991","volume":"38","author":"Salvarani","year":"1995","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib17","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/rheumatology\/34.3.261","article-title":"Epidemiology and mortality in 220 patients with polymyalgia rheumatica","volume":"34","author":"Schaufelberger","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/art.1780300308","article-title":"Giant cell arteritis, temporal arteritis and polymyalgia rheumatica in a Danish County: a prospective investigation, 1982\u20131985","volume":"30","author":"Boesen","year":"1987","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib19","first-page":"1326","article-title":"The spectrum of polymyalgia rheumatica in Northwestern Spain: incidence and analysis of variables associated with relapse in a ten-year study","volume":"26","author":"Gonz\u00e1lez-Gay","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/art.1780340313","article-title":"Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in Northern Italy","volume":"34","author":"Salvarani","year":"1991","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/ard.2005.046912","article-title":"Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990\u20132001","volume":"65","author":"Smeeth","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.24793","article-title":"Polymyalgia rheumatica prevalence in a population-based sample","volume":"61","author":"Bernatsky","year":"2009","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780170105","article-title":"Familial aggregation of polymyalgia rheumatica and giant cell arteritis","volume":"17","author":"Liang","year":"1974","journal-title":"Arthritis & Rheumatism"},{"issue":"1 Suppl. 52","key":"10.1016\/j.berh.2012.01.007_bib24","first-page":"S89","article-title":"Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families","volume":"27","author":"Liozon","year":"2009","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib25","first-page":"2140","article-title":"Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association","volume":"25","author":"Dababneh","year":"1998","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib26","first-page":"259","article-title":"Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and t cell repertoire analysis","volume":"19","author":"Bartolome","year":"2001","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib27","first-page":"502","article-title":"Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica","volume":"29","author":"Amoli","year":"2002","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/rheumatology\/kel324","article-title":"Contribution of MHC class I region to genetic susceptibility for giant cell arteritis","volume":"46","author":"Gonzales-Gay","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib29","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/ard.2005.038901","article-title":"Seasonal pattern in the onset of polymyalgia rheumatica","volume":"64","author":"Perfetto","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/ken437","article-title":"Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the gracg prospective study","volume":"48","author":"Schmidt","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/0961203311430222","article-title":"Giant cell arteritis and polymaylgia rheumatica after influenza vaccination. Report of 10 Cases and Review of the Literature","volume":"21","author":"Soriano","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2012.01.007_bib32","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA Syndrome\u2019 \u2013 autoimmune-inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.berh.2012.01.007_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/ard.2008.103663","article-title":"Circulating cytokines in active polymyalgia rheumatica","volume":"69","author":"Alvarez-Rodr\u00edguez","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib34","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/rheumatology\/39.6.624","article-title":"The adrenal steroid status in relation to inflammatory cytokines (interleukin-6 and tumour necrosis factor) in polymyalgia rheumatica","volume":"39","author":"Straub","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/art.1780360913","article-title":"Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis","volume":"36","author":"Roche","year":"1993","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib36","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/rheumatology\/37.7.766","article-title":"Cytokines and adhesion molecules in patients with polymyalgia rheumatica","volume":"37","author":"Uddhammar","year":"1998","journal-title":"British Journal of the Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2008.09.004","article-title":"Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment","volume":"44","author":"Martinez-Taboada","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.berh.2012.01.007_bib38","first-page":"1318","article-title":"Favorable role of interleukin 10 in patients with polymyalgia rheumatica","volume":"26","author":"Straub","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib39","first-page":"655","article-title":"Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis driven disease","volume":"18","author":"Cutolo","year":"2000","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1053\/sarh.2003.49993","article-title":"Hypotalamic-pituitary-adrenocortical axis function in patients with polymyalgia rheumatica and giant cell arteritis","volume":"32","author":"Pacheco","year":"2003","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib41","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3899\/jrheum.091283","article-title":"More night than day-circadian rhythms in polymyalgia rheumatica and ankylosing spondylitis","volume":"37","author":"Spies","year":"2010","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib42","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/ard.2010.140194","article-title":"Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis","volume":"70","author":"Alvarez-Rodriguez","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib43","article-title":"Toll-Like receptor 4 gene polymorphisms in polymyalgia rheumatica and elderly-onset rheumatoid arthritis","author":"Alvarez-Rodriguez","year":"2011","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-121-7-199410010-00003","article-title":"Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis","volume":"121","author":"Weyand","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/rheumatology\/38.5.444","article-title":"New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography","volume":"38","author":"Blockmans","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2165\/11592500-000000000-00000","article-title":"Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management","volume":"28","author":"Schmidt","year":"2011","journal-title":"Drugs Aging"},{"key":"10.1016\/j.berh.2012.01.007_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.rhu.0000231381.21179.e6","article-title":"Peripheral musculoskeletal manifestations in polymyalgia rheumatica","volume":"12","author":"Ceccato","year":"2006","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib48","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: a five-year epidemiologic and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani","year":"1987","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/BOR.0b013e3283410072","article-title":"Lower extremities vasculitis in polymyalgia rheumatica and giant cell arteritis","volume":"23","author":"Kermani","year":"2011","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib50","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.1997.00440240081012","article-title":"Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate: a more benign syndrome","volume":"157","author":"Gonzalez-Gay","year":"1997","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/sarh.2000.8366","article-title":"Erythrocyte sedimentation rate and c-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a propective follow-up study","volume":"30","author":"Cantini","year":"2000","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib52","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1136\/ard.2002.002618","article-title":"EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European collaborating polymyalgia rheumatica group (Subcommittee of ESCISIT)","volume":"62","author":"Leeb","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib53","article-title":"Imaging of polymyalgia rheumatica: indications on its pathogenesis","author":"Camellino","year":"2011","journal-title":"Diagnosis and Prognosis. Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib54","first-page":"462","article-title":"Inflammatory changes of hip synovial structures in polymyalgia rheumatica","volume":"23","author":"Cantini","year":"2005","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib55","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/1529-0131(200105)44:5<1155::AID-ANR198>3.0.CO;2-N","article-title":"Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate","volume":"44","author":"Cantini","year":"2001","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib56","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.berh.2004.06.003","article-title":"Polymalgia rheumatica","volume":"18","author":"Salvarani","year":"2004","journal-title":"Best Practice and Research. Clinical Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib57","first-page":"88","article-title":"US Imaging of shoulder fascititis due to polymyalgia rheumatica","volume":"66","author":"Rozin","year":"2008","journal-title":"The Netherlands Journal of Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib58","first-page":"1049","article-title":"Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study","volume":"28","author":"Cantini","year":"2001","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib59","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/ard.2007.084723","article-title":"Cervical interspinous bursitis in active polymyalgia rheumatica","volume":"67","author":"Salvarani","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/rheumatology\/ken343","article-title":"Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a five-year prospective study","volume":"48","author":"Pease","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib61","article-title":"What does imaging tell us about polymyalgia rheumatica?","author":"Breuer","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib62","first-page":"644","article-title":"Evidence for synovitis in active polymyalgia rheumatica: sonographic study in a large series of patients","volume":"29","author":"Frediani","year":"2002","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib63","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199711063371902","article-title":"Color duplex ultrasonography in the diagnosis of temporal arteritis","volume":"337","author":"Schmidt","year":"1997","journal-title":"The New England Journal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-137-4-200208200-00006","article-title":"Is duplex ultrasonography useful for the diagnosis of giant cell arteritis?","volume":"137","author":"Salvarani","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib65","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/ard.2009.113555","article-title":"Ultrasonographic monitoring of response to therapy in polymyalgia rheumatica","volume":"69","author":"Jimenez-Palop","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-127-1-199707010-00005","article-title":"Proximal bursitis in active polymyalgia rheumatica","volume":"127","author":"Salvarani","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib67","first-page":"1837","article-title":"Comparison of extra-capsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica","volume":"28","author":"McGonagle","year":"2001","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s10165-007-0595-6","article-title":"Clinical characteristics of polymyalgia rheumatica in japanese patients: evidence of synovitis and extracapsular inflammatory changes by fat suppression magnetic resonance imaging","volume":"17","author":"Mori","year":"2007","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib69","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/art.22942","article-title":"Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis","volume":"56","author":"Marzo-Ortega","year":"2007","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib70","first-page":"119","article-title":"MRI of musculature in myalgia \u2013 indications and image findings","volume":"6","author":"Beese","year":"1996","journal-title":"Aktuelle Radiologie"},{"key":"10.1016\/j.berh.2012.01.007_bib71","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/art.1780401014","article-title":"P-31 Magnetic resonance spectroscopy demonstrates unaltered muscle energy utilization in polymyalgia rheumatica","volume":"40","author":"Mattei","year":"1997","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib72","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/rheumatology\/kel376","article-title":"Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients","volume":"46","author":"Blockmans","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib73","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/rheumatology\/ken098","article-title":"Is FDG-PET useful in the evaluation of steroid-resistant PMR patients?","volume":"47","author":"Cimmino","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib74","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1749-6632.2011.06021.x","article-title":"PET in vasculitis","volume":"1228","author":"Blockmans","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.berh.2012.01.007_bib75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/rheumatology\/kep303a","article-title":"BSR and BHPR Standards, guidelines and audit working group. BSR and BHPR guidelines for the management of polymyalgia rheumatica","volume":"49","author":"Dasgupta","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib76","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/ard.48.8.658","article-title":"Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months","volume":"48","author":"Kyle","year":"1989","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib77","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/ard.48.8.662","article-title":"Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects","volume":"48","author":"Kyle","year":"1989","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2474-12-94","article-title":"The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity","volume":"12","author":"Cimmino","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1016\/j.berh.2012.01.007_bib79","first-page":"270","article-title":"Members of the American College of Rheumatology Work Group for development of classification criteria for PMR. Developing classification criteria for polymyalgia rheumatica: comparison of views from an expert panel and wider survey","volume":"35","author":"Dasgupta","year":"2008","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib80","doi-asserted-by":"crossref","first-page":"c620","DOI":"10.1136\/bmj.c620","article-title":"Management of polymyalgia rheumatica","volume":"340","author":"Ntatsaki","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2012.01.007_bib81","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2012.01.007_bib82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.20901","article-title":"Acute-phase reactants and the risk of relapse\/recurrence in polymyalgia rheumatica: a prospective follow-up study","volume":"53","author":"Salvarani","year":"2005","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib83","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","article-title":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a delphi-based expert consensus","volume":"70","author":"Dejaco","year":"2011","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib84","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/ard.2007.072157","article-title":"EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic disease","volume":"66","author":"Hoes","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib85","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/art.1780401022","article-title":"Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica","volume":"40","author":"Gabriel","year":"1997","journal-title":"Arthritis & Rheumatism"},{"key":"10.1016\/j.berh.2012.01.007_bib86","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/03009741003631479","article-title":"Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica","volume":"39","author":"Kreiner","year":"2010","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib87","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1749-6632.2009.05364.x","article-title":"Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica","volume":"1193","author":"Cimmino","year":"2010","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.berh.2012.01.007_bib88","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American college of rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.berh.2012.01.007_bib89","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/rheumatology\/37.2.189","article-title":"An initially double-blind controlled 96-week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica","volume":"37","author":"Dasgupta","year":"1998","journal-title":"British Journal Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib90","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of large vessels vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5 Suppl. 61","key":"10.1016\/j.berh.2012.01.007_bib91","first-page":"S172","article-title":"Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica","volume":"28","author":"Spies","year":"2010","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1016\/j.berh.2012.01.007_bib92","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-141-7-200410050-00005","article-title":"Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial","volume":"141","author":"Caporali","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib93","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.55.4.218","article-title":"Can methotrexate be used as a steroid-sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?","volume":"55","author":"Van der Veen","year":"1996","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2012.01.007_bib94","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-146-9-200705010-00005","article-title":"Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial","volume":"146","author":"Salvarani","year":"2007","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.berh.2012.01.007_bib95","doi-asserted-by":"crossref","first-page":"R176","DOI":"10.1186\/ar3140","article-title":"Effect of etanercept in polymyalgia rheumatica: a randomized controlled trial","volume":"12","author":"Kreiner","year":"2010","journal-title":"Arthritis Research & Therapy"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694212000083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694212000083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T07:52:07Z","timestamp":1543132327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694212000083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1521694212000083"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2012.01.007","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}